Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study

Background: The correction of iron deficiency (ID) with ferric carboxymaltose (FCM) is a recommended intervention in heart failure (HF) with reduced ejection fraction. Our aim is to evaluate, in a real-life setting, the clinical significance of ID screening and FCM treatment in acute decompensated H...

Descripción completa

Detalles Bibliográficos
Autores principales: Capone, Federico, Cipriani, Alberto, Molinari, Leonardo, Noale, Marianna, Gusella, Beatrice, Lucente, Fabrizio, Savino, Sandro, Bertomoro, Antonella, Saller, Alois, Giannini, Sandro, Vettor, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455601/
https://www.ncbi.nlm.nih.gov/pubmed/37623500
http://dx.doi.org/10.3390/jpm13081250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455601/
https://www.ncbi.nlm.nih.gov/pubmed/37623500
http://dx.doi.org/10.3390/jpm13081250

Ejemplares similares